This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

proofread

How inflammation in COVID-19 alters the smallest vessels in the heart

How inflammation in COVID 19 alters the smallest vessels in the heart
A–D MPX staining of cardiac tissue depicting CD68 + macrophages in orange, CD4 + T helper cells in green, CD8 + cytotoxic T cells in yellow, and CD20 + B-cells in magenta. All infected hearts (COVID-19, influenza, and lymphocytic non-influenza myocarditis) displayed a prominent infiltrate of CD68 + macrophages. While COVID-19 A (COVID-19 patient ID 24) and influenza, B (Influenza patient ID 9) hearts showed nearly absent lymphocytic infiltrate, lymphocytic non-influenza myocarditis, C (Myocarditis patient ID 5) was characterized by a mixed, T-cell dominated infiltrate. Non-infected control hearts, D (Control patient ID 1) showed markedly less inflammatory cells with a mixed population of macrophages and predominant t-cells and only scarce B-cells. Magnification 400x. Scale bars = 100 µm. E Histogram of the inflammatory cell infiltrates (CD20, CD4, CD68, CD8). Cell counts are normalized to cells per mm2 myocardial tissue. *p < 0.05, **p < 0.01, ***p < 0.001. Credit: Angiogenesis (2022). DOI: 10.1007/s10456-022-09860-7

Severe courses of COVID-19 infection not only impair lung function, but can also cause life-threatening consequences for the heart. The spectrum ranges from acute inflammation of the heart muscle (myocarditis) to chronic restriction of the heart's pumping function. The basic patterns of damage have not yet been completely proven.

An interdisciplinary research team led by Professor Dr. Danny Jonigk, Christopher Werlein and Private Lecturer (PD) Dr. Mark Kühnel from the Institute of Pathology at the Hannover Medical School (MHH) has now used innovative molecular methods and a high-resolution microscopy technique to show how the ongoing inflammation in COVID-19 attacks the and, in the long term, remodels the smallest coronary vessels by directing special precursor cells of the immune system from the blood into the heart. The study was published in the journal Angiogenesis.

False-activated inflammatory cells

About one in three people complain of discomfort and functional impairment of the heart after severe COVID-19 disease. In order to elucidate the mechanisms of this long-lasting myocardial damage, the researchers examined heart tissue from patients with severe COVID 19 and compared it with taken after severe influenza infections caused by the and after severe myocarditis caused by other viruses.

Although in the COVID 19 heart injury—unlike the comparison samples—there was no classic inflammation of the heart tissue on the outside, the research team did find a large accumulation of false-activated inflammatory cells: so-called macrophages and their precursor cells, the monocytes. "These monocytes have an outstanding importance as precursor cells of new blood vessel formation and can remodel the blood vessel system in a very short time," explains Christopher Werlein, first author of the study.

COVID-19 attacks all vessels in the body

Triggered by the infection with the coronavirus SARS-CoV-2, tiny blockages accumulate in the heart vessels, which are only a few millimeters thick. "These ultra-thrombi change the considerably and thus also the ," emphasizes PD Dr. Kühnel. This calls the monocytes into action, which attach themselves to the inner walls and form new branches there.

This vascular remodeling—known as intussusceptive angiogenesis—has already been described by the team as a characteristic pattern of damage in other organs of COVID 19 patients. What may be intended as a short-term rescue response by the body to compensate for reduced blood flow and undersupply of oxygen could lead to chronic damage to the and long COVID, the researchers suspect.

"In any case, the latest investigations confirm our earlier assumption that SARS-CoV-2 systemically attacks all vessels in the body and remodels them in the long term," Professor Jonigk emphasizes.

More information: Christopher Werlein et al, Inflammation and vascular remodeling in COVID-19 hearts, Angiogenesis (2022). DOI: 10.1007/s10456-022-09860-7

Provided by Medizinische Hochschule Hannover
Citation: How inflammation in COVID-19 alters the smallest vessels in the heart (2023, January 5) retrieved 14 June 2024 from https://medicalxpress.com/news/2023-01-inflammation-covid-smallest-vessels-heart.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Study reveals how COVID damages the heart

12 shares

Feedback to editors